CTI BIOPHARMA CORP: accounts_payable
| Value | {"amount": 5491000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-03-31) |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dcf3c29a-eb6f-4916-afbc-e8c22a9166d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-173261 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/accounts-payable/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dcf3c29a-eb6f-4916-afbc-e8c22a9166d5
History
- no predecessors — first report